Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer

Breast Cancer Research

Volumn 14, Issue 5, 2012, Pages

  Agarwal, Seema ^a   Gertler, Frank B ^b   Balsamo, Michele ^b   Condeelis, John S ^c   Camp, Robert L ^a   Xue, Xiaonan ^c   Lin, Juan ^c   Rohan, Thomas E ^c   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MENA; PROTEIN MENA CALC; TUMOR MARKER; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; ENAH PROTEIN, HUMAN; ISOPROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER INVASION; DISEASE SPECIFIC SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MULTIPLEX QUANTITATIVE IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; AGED; BREAST TUMOR; COHORT ANALYSIS; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; SURVIVAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; PROTEIN ISOFORMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84866041637     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3318     Document Type: Article

References (22)

1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564. 10.1126/science.1203543, 21436443.
2. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292. 10.1016/j.cell.2011.09.024, 3261217, 22000009.
3. Gertler FB, Niebuhr K, Reinhard M, Wehland J, Soriano P. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 1996, 87:227-239. 10.1016/S0092-8674(00)81341-0, 8861907.
4. Bear JE, Gertler FB. Ena/VASP: towards resolving a pointed controversy at the barbed end. J Cell Sci 2009, 122:1947-1953. 10.1242/jcs.038125, 2723151, 19494122.
5. Wang W, Eddy R, Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007, 7:429-440. 10.1038/nrc2148, 17522712.
6. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004, 64:8585-8594. 10.1158/0008-5472.CAN-04-1136, 15574765.
7. Gertler F, Condeelis J. Metastasis: tumor cells becoming MENAcing. Trends Cell Biol 2011, 21:81-90. 10.1016/j.tcb.2010.10.001, 3402095, 21071226.
8. Small JV. Facing up to Mena: tes(ting) times for EVH1 domains. Nat Cell Biol 2008, 10:118-120. 10.1038/ncb0208-118, 18246036.
9. Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, Condeelis JS, Jones JG. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 2009, 15:2433-2441. 10.1158/1078-0432.CCR-08-2179, 3156570, 19318480.
10. Roussos ET, Wang Y, Wyckoff JB, Sellers RS, Wang W, Li J, Pollard JW, Gertler FB, Condeelis JS. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors. Breast Cancer Res 2010, 12:R101. 10.1186/bcr2784, 3046446, 21108830.
11. Goswami S, Philippar U, Sun D, Patsialou A, Avraham J, Wang W, Di Modugno F, Nistico P, Gertler FB, Condeelis JS. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis 2009, 26:153-159. 10.1007/s10585-008-9225-8, 3042857, 18985426.
12. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 2011, 7:e1002218. 10.1371/journal.pgen.1002218, 3158048, 21876675.
13. Philippar U, Roussos ET, Oser M, Yamaguchi H, Kim HD, Giampieri S, Wang Y, Goswami S, Wyckoff JB, Lauffenburger DA, Sahai E, Condeelis JS, Gertler FB. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 2008, 15:813-828. 10.1016/j.devcel.2008.09.003, 2637261, 19081071.
14. Roussos ET, Balsamo M, Alford SK, Wyckoff JB, Gligorijevic B, Wang Y, Pozzuto M, Stobezki R, Goswami S, Segall JE, Lauffenburger DA, Bresnick AR, Gertler FB, Condeelis JS. Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J Cell Sci 2011, 124:2120-2131. 10.1242/jcs.086231, 3113666, 21670198.
15. Roussos ET, Goswami S, Balsamo M, Wang Y, Stobezki R, Adler E, Robinson BD, Jones JG, Gertler FB, Condeelis JS, Oktay MH. Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM. Clin Exp Metastasis 2011, 28:515-527. 10.1007/s10585-011-9388-6, 3459587, 21484349.
16. Pino MS, Balsamo M, Di Modugno F, Mottolese M, Alessio M, Melucci E, Milella M, McConkey DJ, Philippar U, Gertler FB, Natali PG, Nisticò P. Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines. Clin Cancer Res 2008, 14:4943-4950. 10.1158/1078-0432.CCR-08-0436, 2586967, 18676769.
17. Giltnane JM, Moeder CB, Camp RL, Rimm DL. Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort. Cancer 2009, 115:2400-2409. 10.1002/cncr.24277, 2756449, 19330842.
18. Welsh AW, Moeder CB, Kumar S, Gershkovich P, Alarid ET, Harigopal M, Haffty BG, Rimm DL. Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. J Clin Oncol 2011, 29:2978-2984. 10.1200/JCO.2010.32.9706, 3157961, 21709197.
19. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002, 8:1323-1327. 10.1038/nm791, 12389040.
20. Moeder CB, Giltnane JM, Moulis SP, Rimm DL. Quantitative, fluorescence-based in-situ assessment of protein expression. Methods Mol Biol 2009, 520:163-175. 10.1007/978-1-60327-811-9_12, 19381954.
21. Anagnostou VK, Lowery FJ, Syrigos KN, Cagle PT, Rimm DL. Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?. Arch Pathol Lab Med 2010, 134:613-619.
22. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000, 80:1943-1949. 10.1038/labinvest.3780204, 11140706.